AOP Orphan is a European pioneer in the development, production and marketing of treatments for people with rare diseases also known as orphan diseases.
"Our goal is to enlarge our portfolio with efficient drugs bringing innovative treatments to patients with rare diseases. Therefore our focus in 2019 is to get new molecules included on the reimbursement list offering Romanian patients high standard therapies as all EU citizens are entitled to.
We work together as a dynamic, flexible and passionate team with great motivation and commitment to achieve this aim!"
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Romanian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of rare diseases.
Romania occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2008. AOP Orphan Romania is a team of around five employees in the Marketing & Sales, and Medical for all three therapeutic divisions.
Being a part of AOP Orphan team simply means enjoying the work, being committed to a team that values the efforts towards building up a strong business with integrity. Since the foundation we at AOP Orphan remain committed to ongoing dialogue with the scientific community and by supporting medical education we will improve also patients’ care.
At AOP Orphan we have the opportunity to develop the full potential while contributing to the success of the company. Our local environment encourages our colleagues to achieve sustainable performance.